866-997-4948(US-Canada Toll Free)

Wound Closure Devices - Medical Devices Pipeline Assessment, 2017

Published By :

GlobalData

Published Date : Nov 2017

Category :

Wound Care

No. of Pages : 538 Pages

Wound Closure Devices - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, Wound Closure Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Wound Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wound Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Wound Closure Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Wound Closure Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 21
2 Introduction 22
2.1 Wound Closure Devices Overview 22
3 Products under Development 25
3.1 Wound Closure Devices - Pipeline Products by Stage of Development 25
3.2 Wound Closure Devices - Pipeline Products by Territory 26
3.3 Wound Closure Devices - Pipeline Products by Regulatory Path 28
3.4 Wound Closure Devices - Pipeline Products by Estimated Approval Date 29
3.5 Wound Closure Devices - Ongoing Clinical Trials 30
4 Wound Closure Devices - Pipeline Products under Development by Companies 31
4.1 Wound Closure Devices Companies - Pipeline Products by Stage of Development 31
4.2 Wound Closure Devices - Pipeline Products by Stage of Development 35
5 Wound Closure Devices Companies and Product Overview 40
5.1 3-D Matrix Ltd Company Overview 40
5.2 Actamax Surgical Materials LLC Company Overview 44
5.3 Adhesys Medical GmbH Company Overview 45
5.4 Advanced Medical Solutions Group plc Company Overview 48
5.5 Alafair Biosciences Inc Company Overview 53
5.6 Alumend LLC Company Overview 54
5.7 Anika Therapeutics Inc Company Overview 55
5.8 Arch Therapeutics Inc Company Overview 56
5.9 Argon Medical Devices Inc Company Overview 58
5.10 Aura Medsystems, Inc. Company Overview 60
5.11 Baxter International Inc Company Overview 61
5.12 Bayer HealthCare AG (Inactive) Company Overview 66
5.13 Bergen Medical Products Inc Company Overview 67
5.14 Beth Israel Deaconess Medical Center Inc Company Overview 68
5.15 Biomedica Management Corp Company Overview 69
5.16 Biom'Up SAS Company Overview 72
5.17 Boston University Company Overview 75
5.18 C. R. Bard Inc Company Overview 76
5.19 Calmare Therapeutics Inc Company Overview 81
5.20 CardioCommand Inc Company Overview 82
5.21 Cellphire Inc Company Overview 83
5.22 Ceramicos Para Aplicacoes Medicas Lda Company Overview 85
5.23 Clemson University Company Overview 86
5.24 Cohera Medical Inc Company Overview 87
5.25 Columbia University Company Overview 93
5.26 CorMedix Inc Company Overview 94
5.27 Covalent Medical, Inc. (Inactive) Company Overview 95
5.28 Covalon Technologies Ltd Company Overview 97
5.29 Cresilon Inc Company Overview 99
5.30 CryoLife Inc Company Overview 101
5.31 CSMG Technologies, Inc. (Inactive) Company Overview 104
5.32 Daewoong Pharmaceutical Co Ltd Company Overview 105
5.33 Dermtreat ApS Company Overview 110
5.34 DSM Biomedical BV Company Overview 113
5.35 Emory University Company Overview 114
5.36 Endomedix Incorporated Company Overview 115
5.37 Entegrion Inc Company Overview 117
5.38 Ethicon Endo-Surgery Inc Company Overview 118
5.39 Ethicon US LLC Company Overview 119
5.40 Gamma Therapeutics Inc Company Overview 122
5.41 Gecko Biomedical Company Overview 124
5.42 gel-e Inc Company Overview 127
5.43 Grifols SA Company Overview 129
5.44 Haemostatix Ltd Company Overview 130
5.45 Hemostasis LLC Company Overview 134
5.46 HyperBranch Medical Technology Inc Company Overview 137
5.47 Innocoll Technologies Ltd Company Overview 139
5.48 Institute of Molecular Biology of Parana Company Overview 140
5.49 Integra LifeSciences Holdings Corp Company Overview 141
5.50 InVivo Therapeutics Corp Company Overview 144
5.51 IonMed Ltd. Company Overview 145
5.52 John Hopkins University Company Overview 147
5.53 KeraNetics, LLC Company Overview 148
5.54 Kitotech Medical, Inc. Company Overview 149
5.55 Kollodis BioSciences Inc Company Overview 151
5.56 Kuros Biosciences AG Company Overview 153
5.57 Kytogenics Pharmaceuticals Inc Company Overview 155
5.58 Laser Tissue Welding, Inc. Company Overview 156
5.59 Latch Medical Ltd Company Overview 159
5.60 Lenvitz Medical Solutions Pvt. Ltd. Company Overview 160
5.61 Life Care Medical Devices Limited Company Overview 161
5.62 LifeBond Ltd Company Overview 162
5.63 Maxigen Biotech Inc Company Overview 168
5.64 Medisse BV (Inactive) Company Overview 169
5.65 Medtronic plc Company Overview 172
5.66 MLM Biologics Inc Company Overview 174
5.67 Northwestern University Company Overview 176
5.68 OptMed, Inc. Company Overview 177
5.69 PetVivo Holdings Inc Company Overview 180
5.70 Pharming Group NV Company Overview 181
5.71 Polyganics BV Company Overview 182
5.72 Protein Polymer Technologies Inc (Inactive) Company Overview 188
5.73 Regenics AS Company Overview 190
5.74 Resorba GmbH Company Overview 192
5.75 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 197
5.76 Rice University Company Overview 198
5.77 Samyang Biopharmaceuticals Corp Company Overview 199
5.78 Sanofi Company Overview 201
5.79 Sea Run Holdings Inc Company Overview 203
5.80 Sealantis Ltd. Company Overview 205
5.81 Seraffix Ltd Company Overview 207
5.82 Shanghai Haohai Biological Technology Co Ltd Company Overview 208
5.83 Sheba Medical Center Company Overview 210
5.84 St Teresa Medical Inc Company Overview 211
5.85 Surgical Energetics LLC Company Overview 213
5.86 Surgical Sealants, Inc. Company Overview 214
5.87 Teijin Pharma Ltd Company Overview 215
5.88 Texas A&M University Company Overview 216
5.89 The Medicines Company Company Overview 218
5.90 ThermoTek, Inc. Company Overview 220
5.91 Therus Corporation Company Overview 221
5.92 Thrombotargets Corp Company Overview 222
5.93 Tribos LLC Company Overview 224
5.94 Tricol Biomedical Inc Company Overview 225
5.95 United Health Products, Inc. Company Overview 226
5.96 University of Akron Company Overview 229
5.97 University of Grenoble Alpes Company Overview 230
5.98 University of Kansas Company Overview 231
5.99 University of Toledo Company Overview 232
5.100 Vigor Medical Technologies Ltd. Company Overview 233
5.101 Virginia Commonwealth University Company Overview 234
5.102 Wound Management Technologies Inc Company Overview 235
5.103 WoundZipper Inc Company Overview 236
5.104 Xcede Technologies Inc Company Overview 237
6 Wound Closure Devices- Recent Developments 240
6.1 Sep 20, 2017: Actamax receives approval to begin pivotal clinical trial for Actamax Adhesion Barrier 240
6.2 Sep 19, 2017: Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update 240
6.3 Sep 19, 2017: Organogenesis Names New Chief Commercial Officer and Chief Operating Officer 241
6.4 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 243
6.5 Sep 13, 2017: Advanced Medical Solutions: Interim Results for the six months ended 30 June 2017 244
6.6 Sep 13, 2017: MiMedx Reiterates Its Third Quarter Revenue Expectation To Exceed $80 Million Despite Hurricane Irma 244
6.7 Sep 13, 2017: gel-e Expands Core Team with Regulatory, Manufacturing and Financial Talent 245
6.8 Sep 12, 2017: Arch Therapeutics Reports Favorable Results in Repeat Dose Testing of AC5 for Subchronic Systemic Toxicity 245
6.9 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director 246
6.10 Sep 11, 2017: Gecko Biomedical receives CE Mark Approval for SETALUM Sealant 247
6.11 Sep 07, 2017: St. Teresa Medical Announces First Commercial Use of SURGICLOT in Auckland, New Zealand 247
6.12 Sep 05, 2017: Polyganics Extends Global Distribution Network with the Addition of Multiple US Distributors 248
6.13 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery 249
6.14 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs 250
6.15 Aug 24, 2017: Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN 251
6.16 Aug 23, 2017: Henry Ford Hospital CEO Announces Retirement 251
6.17 Aug 22, 2017: United Health Products Reports Second Quarter 2017 Results 252
6.18 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 252
6.19 Aug 21, 2017: WoundZipper Earns Patent for Magnetic Non-Suture Wound Closure Device 254
6.20 Aug 21, 2017: Covalon Releases Third Quarter Financial Results 255
6.21 Aug 15, 2017: Multiple Postmarket Clinical Studies Nearing Completion in Europe, Supporting Broad Range of Applications for TissuGlu Surgical Adhesive 256
6.22 Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 257
6.23 Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results 259
6.24 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 262
6.25 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance 262
6.26 Aug 02, 2017: United Health Products Reports Profitable First Quarter ended March 31, 2017 263
6.27 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 264
6.28 Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 264
6.29 Jul 31, 2017: Advanced Medical Solutions Group Reports H1 2016 Results 266
6.30 Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER 266
6.31 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 273
6.32 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions 273
6.33 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 280
6.34 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 281
6.35 Jul 27, 2017: Stryker reports second quarter 2017 results 284
6.36 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President 285
6.37 Jul 27, 2017: JustRight Surgical Announces New CEO 286
6.38 Jul 26, 2017: MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance 286
6.39 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 289
6.40 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 291
6.41 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 292
6.42 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 293
6.43 Jul 25, 2017: Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5 Topical Gel 294
6.44 Jul 24, 2017: Ergomed completes Phase IIb study recruitment six months ahead of schedule for its innovative coagulant PeproStat 295
6.45 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 295
6.46 Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter 297
6.47 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 297
6.48 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 299
6.49 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range 299
6.50 Jul 12, 2017: TissuGlu Surgical Adhesive facilitates drain-free mastectomy 300
6.51 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication 301
6.52 Jul 10, 2017: InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer 302
6.53 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down 303
6.54 Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies 304
6.55 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 304
7 Appendix 533
7.1 Methodology 533
7.2 About GlobalData 536
7.3 Contact Us 536
7.4 Disclaimer 536

1.1 List of Tables
Table 1: Wound Closure Devices - Pipeline Products by Stage of Development 27
Table 2: Wound Closure Devices - Pipeline Products by Territory 29
Table 3: Wound Closure Devices - Pipeline Products by Regulatory Path 30
Table 4: Wound Closure Devices - Pipeline Products by Estimated Approval Date 31
Table 5: Wound Closure Devices - Ongoing Clinical Trials 32
Table 7: Wound Closure Devices Companies - Pipeline Products by Stage of Development 33
Table 8: Wound Closure Devices - Pipeline Products by Stage of Development 37
Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
Table 10: PuraStat Hemostat - Product Status 42
Table 11: PuraStat Hemostat - Product Description 43
Table 12: TDM-511 - Product Status 43
Table 13: TDM-511 - Product Description 43
Table 14: 3-D Matrix Ltd - Ongoing Clinical Trials Overview 44
Table 15: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery 45
Table 16: PuraStat Hemostat - Randomized Controlled Trial Comparing Purastat to Standard Therapy for Haemostasis Control During Endoscopic Submucosal Dissection 45
Table 17: Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview 46
Table 18: Actamax Adhesion Barrier - Product Status 46
Table 19: Actamax Adhesion Barrier - Product Description 46
Table 20: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 47
Table 21: CUTIS - Product Status 47
Table 22: CUTIS - Product Description 47
Table 23: Tissue Adhesive - Pancreatectomy - Product Status 48
Table 24: Tissue Adhesive - Pancreatectomy - Product Description 48
Table 25: VIVO - Product Status 48
Table 26: VIVO - Product Description 49
Table 27: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 28: LiquiBand - Product Status 50
Table 29: LiquiBand - Product Description 50
Table 30: LiquiBand Exceed - Product Status 51
Table 31: LiquiBand Exceed - Product Description 51
Table 32: LiquiBand Flow Control - Product Status 51
Table 33: LiquiBand Flow Control - Product Description 52
Table 34: Next Generation Internal Fixation And Sealant Device - Product Status 52
Table 35: Next Generation Internal Fixation And Sealant Device - Product Description 52
Table 36: Advanced Medical Solutions Group plc - Ongoing Clinical Trials Overview 53
Table 37: LiquiBand Exceed - Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery 54
Table 38: Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 39: VersaWrap Adhesion Barrier - Product Status 55
Table 40: VersaWrap Adhesion Barrier - Product Description 55
Table 41: Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview 56
Table 42: Tissue-Bonding Adhesive - Product Status 56
Table 43: Tissue-Bonding Adhesive - Product Description 56
Table 44: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 57
Table 45: Hemostatic Patch - Product Status 57
Table 46: Hemostatic Patch - Product Description 57
Table 47: Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 48: AC5 Surgical Hemostatic Device - Product Status 58
Table 49: AC5 Surgical Hemostatic Device - Product Description 58
Table 50: AC5 Surgical Hemostatic Device - Internal Use - Product Status 59
Table 51: AC5 Surgical Hemostatic Device - Internal Use - Product Description 59
Table 52: Argon Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 53: Hemaseel HMN Fibrin Sealant - Product Status 60
Table 54: Hemaseel HMN Fibrin Sealant - Product Description 60
Table 55: Hemaseel Thrombin Haemostatic Agent - Product Status 61
Table 56: Hemaseel Thrombin Haemostatic Agent - Product Description 61
Table 57: Aura Medsystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
Table 58: LaSTR - Skin Closure Device - Product Status 62
Table 59: LaSTR - Skin Closure Device - Product Description 62
Table 60: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 61: Hemopatch - Product Status 63
Table 62: Hemopatch - Product Description 64
Table 63: Tisseel Dura - Product Status 64
Table 64: Tisseel Dura - Product Description 64
Table 65: Baxter International Inc - Ongoing Clinical Trials Overview 65
Table 66: Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL) 66
Table 67: Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant 66
Table 68: Hemopatch - Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the use of the New Hemostatic Patch Hemopatch in Patients undergoing Surgical Liver Resection 66
Table 69: Hemopatch - Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection with Hemopatch Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial 67
Table 70: Hemopatch - Prospective, Multicenter, Open-label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak after Lung Resection in High-risk Patients, Applying HEMOPATCH 67
Table 71: Bayer HealthCare AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 68
Table 72: Polyurethane Adhesive System - Product Status 68
Table 73: Polyurethane Adhesive System - Product Description 68
Table 74: Bergen Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Table 75: ACTACLOSE - Product Status 69
Table 76: ACTACLOSE - Product Description 69
Table 77: Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Table 78: Portable Wound Hemostasis System - Product Status 70
Table 79: Portable Wound Hemostasis System - Product Description 70
Table 80: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 71
Table 81: ClotBlock - Product Status 71
Table 82: ClotBlock - Product Description 71
Table 83: ClotFoam - Product Status 72
Table 84: ClotFoam - Product Description 72
Table 85: ClotGel - Product Status 72
Table 86: ClotGel - Product Description 73
Table 87: ClotSpray - Product Status 73
Table 88: ClotSpray - Product Description 73
Table 89: Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview 74
Table 90: Hemoblast Bellows - Product Status 74
Table 91: Hemoblast Bellows - Product Description 74
Table 92: Biom'Up SAS - Ongoing Clinical Trials Overview 75
Table 93: Hemoblast Bellows - Prospective, Randomized, Controlled, Multicenter, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of Hemoblast Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries 76
Table 94: Boston University Pipeline Products & Ongoing Clinical Trials Overview 77
Table 95: Hydrogel-based Aerosolized Sealant Dressing - Product Status 77
Table 96: Hydrogel-based Aerosolized Sealant Dressing - Product Description 77
Table 97: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 78
Table 98: New Hemostat 1 - Product Status 78
Table 99: New Hemostat 1 - Product Description 79
Table 100: New Hemostat 2 - Product Status 79
Table 101: New Hemostat 2 - Product Description 79
Table 102: Progel Dural Sealant - Product Status 80
Table 103: Progel Dural Sealant - Product Description 80
Table 104: Progel Emerald - Product Status 80
Table 105: Progel Emerald - Product Description 81
Table 106: ProGEL-VS - Product Status 81
Table 107: ProGEL-VS - Product Description 81
Table 108: Tridyne Peripheral - Product Status 82
Table 109: Tridyne Peripheral - Product Description 82
Table 110: Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 83
Table 111: Wound Sealant - Product Status 83
Table 112: Wound Sealant - Product Description 83
Table 113: CardioCommand Inc Pipeline Products & Ongoing Clinical Trials Overview 84
Table 114: Tournicath Device - Product Status 84
Table 115: Tournicath Device - Product Description 84
Table 116: Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview 85
Table 117: Thromboderm - Product Status 85
Table 118: Thromboderm - Product Description 85
Table 119: Thrombosomes - Hemostatic Agent - Product Status 86
Table 120: Thrombosomes - Hemostatic Agent - Product Description 86
Table 121: Ceramicos Para Aplicacoes Medicas Lda Pipeline Products & Ongoing Clinical Trials Overview 87
Table 122: HemoKi - Product Status 87
Table 123: HemoKi - Product Description 87
Table 124: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 88
Table 125: Surgical Adhesive Hydrogel - Product Status 88
Table 126: Surgical Adhesive Hydrogel - Product Description 88
Table 127: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 89
Table 128: Sylys Surgical Sealant - Product Status 89
Table 129: Sylys Surgical Sealant - Product Description 90
Table 130: Sylys Surgical Sealant - Drug Delivery - Product Status 90
Table 131: Sylys Surgical Sealant - Drug Delivery - Product Description 90
Table 132: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Status 91
Table 133: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Description 91
Table 134: Sylys Surgical Sealant - Orthopedic Procedures - Product Status 91
Table 135: Sylys Surgical Sealant - Orthopedic Procedures - Product Description 92
Table 136: Cohera Medical Inc - Ongoing Clinical Trials Overview 93
Table 137: Sylys Surgical Sealant - A Pilot, Prospective, Randomized, Controlled, Multicenter Technical Feasibility Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys Surgical Sealant 94
Table 138: Sylys Surgical Sealant - A Pivotal, Prospective, Randomized, Controlled, Multi-center Superiority Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys Surgical Sealant 94
Table 139: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 95
Table 140: Hemostatic Wound Dressing - Product Status 95
Table 141: Hemostatic Wound Dressing - Product Description 95
Table 142: CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 96
Table 143: Taurolidine Wound Closures - Product Status 96
Table 144: Taurolidine Wound Closures - Product Description 96
Table 145: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97
Table 146: Covabond - Product Status 97
Table 147: Covabond - Product Description 97
Table 148: CovaSTAT - Product Status 98
Table 149: CovaSTAT - Product Description 98
Table 150: Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

1.2 List of Figures
Figure 1: Wound Closure Devices - Pipeline Products by Stage of Development 27
Figure 2: Wound Closure Devices - Pipeline Products by Territory 28
Figure 3: Wound Closure Devices - Pipeline Products by Regulatory Path 30
Figure 4: Wound Closure Devices - Pipeline Products by Estimated Approval Date 31
Figure 5: Wound Closure Devices - Ongoing Clinical Trials 32

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *